Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing study of sivelestat sodium hydrate for acute lung injury associated with systemic inflammatory response syndrome
jRCT1080220086Phase 4
- Sponsor
- Ono Pharmaceutical
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of sivelestat in acute lung injury (ALI) and Systemic Inflammatory Response Syndrome (SIRS), sponsored by Ono Pharmaceutical.
02
Drugs
sivelestat
03
Conditions
acute lung injury (ALI)Systemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on jRCT1080220086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080220086.